Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Can GLP-1 weight loss drugs protect your brain as you age?

18

Nov 2026

Can GLP-1 weight loss drugs protect your brain as you age?

A review published in Science examines how GLP-1-based weight loss medications and emerging combination therapies may influence cognitive function through direct neurological mechanisms and improved cardiometabolic health. Observational evidence suggests a lower dementia risk among people with type 2 diabetes taking GLP-1 receptor agonists, but clinical trials have failed to demonstrate convincing benefits in established Alzheimer's disease.

What happens to a baby when its mother catches measles during pregnancy?

18

Nov 2026

What happens to a baby when its mother catches measles during pregnancy?

A preliminary US surveillance report documented 112 cases of measles during pregnancy and 13 cases of congenital measles between January 2025 and September 2026, with complications including maternal pneumonia, preterm delivery, and neonatal intensive care admission. Nearly all affected pregnant individuals were unvaccinated or had unknown vaccination status, reinforcing the importance of MMR vaccination before pregnancy and high community vaccination coverage.

US obesity rates may finally be falling, but weight-loss drugs are only part of the story

18

Nov 2026

US obesity rates may finally be falling, but weight-loss drugs are only part of the story

The 2026 JAMA Summit Report on Obesity examines the biological, socioeconomic, and environmental drivers of the global obesity epidemic, which now affects more than one billion people. The authors suggest that GLP-1 receptor agonists may already be contributing to declining US obesity prevalence, but lasting progress requires healthier food environments, equitable healthcare access, reduced weight stigma, and personalized treatment strategies.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.